Documentation scientifique

Vous trouverez ci-dessous une liste partielle d’articles portant sur le gène GCC. Cette liste sera mise à jour de façon régulière.  Nous vous suggérons de la consulter régulièrement. Pour plus d'articles, cliquer ici.

  1. Mejia, A., and Waldman, S. Previstage™ GCC test for staging patients with colorectal cancer. Expert Reviews 2008; 8 (5): 571-578.
  2. Bilimoria, K.Y., Bentrem, D.J., Stewart, A.K., Talamonti, M.S., Winchester, D.P., Russell, T.R., and Ko, C.Y. Lymph Node Evaluation as a Colon Cancer Quality Measure: A National Hospital Report Card. J Natl Cancer Inst 2008 Sept 9; 352 (1): 1269
  3. Grossman, S. R., Lyle, S., Resnick, M. B., Sabo, E., Lis, R. T., Rosinha, E., Liu, Q., Hsieh, C. C., Bhat, G., Frackelton, A. R., Jr., and Hafer, L. J. p66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIA Colon Cancer. Clin.Cancer Res., 13[19], 5798-5804. 2007
  4. Schulz S, Hyslop T, Haaf J, Bonaccorso C, Nielsen K, Witek ME, Birbe R, Palazzo J, Weinberg D, Waldman SA.  A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.  Clin Cancer Res.  1er août 2006 1;12(15):4545-52
  5. Bustin A, Mueller R. Real-time reverse transcription PCR in the detection of occult disease in colorectal cancer, Mol Aspects Med.  Avril- juin 2006;27(2-3):192-223.
  6. Frick GS, Pitari GM, Weinberg DS, Hyslop T, Schulz S, Waldman SA.  Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.  Expert Rev Mol Diagn.  Septembre 2005;5(5):701-13
  7. Birbe R, Palazzo JP, Walters R, Weinberg D, Schulz S, Waldman SA.  Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.  Hum Pathol.  Février 2005;36(2):170-9
  8. Fava TA, Desnoyers R, Schulz S, Park J, Weinberg D, Mitchell E, Waldman SA.  Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.  J Clin Oncol.  1er Octobre 2001;19(19):3951-9
  9. Pitari GM, Di Guglielmo MD, Park J, Schulz S, Waldman SA.  Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.  Proc Natl Acad Sci U S A.  3 juillet 2001;98(14):7846-51
  10. Gelmann A, Desnoyers R, Cagir B, Weinberg D, Boman BM, Waldman SA.  Colorectal cancer staging and adjuvant chemotherapy.  Expert Opin Pharmacother.  Mai 2000;1(4):737-55
  11. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA.  Guanylyl cyclases and signaling by cyclic GMP.  Pharmacol Rev.  Septembre 2000;52(3):375-414
  12. Cagir B, Gelmann A, Park J, Fava T, Tankelevitch A, Bittner EW, Weaver EJ, Palazzo JP, Weinberg D, Fry RD, Waldman SA.  Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.  Ann Intern Med.  7 décembre 1999;131(11):805-12
  13. Carrithers SL, Barber MT, Biswas S, Parkinson SJ, Park PK, Goldstein SD, Waldman SA.  Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.  Proc Natl Acad Sci U S A.  10 décembre 1996;93(25):14827-32